value
Navigation Links
value at medicine technology
Hemoglobin Testing at the Point of Care
... placed into the portable analyzer. The hemoglobin value appears on the display screen in less than a minute. Hb 201 microcuvettes cannot be used in the B-Hemoglobin system and vice versa. The dual wavelength test procedure corrects for lipemia, leukocytosis and other sources of turbidity. Capillary, veno...New Assays to Detect Disseminated Fungal Infections
..., Fungitell has demonstrated a negative predictive value of 100% and a favorable positive predictive value when serial assays are performed. For detection of Aspergillus , a head-to-head comparison of the ...Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
...trations can decline to the point that therapeutic value is lost. Patients can also carry mutations or duplications in one or more CYP enzymes. Usually unbeknownst to the clinician, these polymorphisms can have pronounced effects on a patients ability to metabolize particular medications. As a result, pa...Appendicitis: Evolving Tools to Diagnose a Classic Disease
...nd loss of appetite have minimal if any predictive value for appendicitis versus other abdominal conditions... tools should provide optimal positive predictive value to facilitate early appendectomy, all in an effort to reduce mortality rates (which can reach 1%). ...Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
...pid tumor growth and a worse prognosis. The real value of the Her-2/neu discovery, and one that helps to counter the poor prognosis of Her-2/neu positive tumors, is that specific therapies such as adriamycin have proven more effective for patients with these tumors. The most celebrated medication, howev...Avian (Bird) Flu: Is There a Role for Rapid Tests?
...ee below), these tests have no positive predictive value for H5N1 versus other subtypes. An equally important question is the negative predictive value of rapid tests. The WHO points out that a negative result on a rapid test does not rule out avian f...Non-Invasive Diagnostic Tests for Celiac Disease
...Biomedical Diagnostics. Even though the predictive value of anti-gliadin antibody (AGA) testing is not as strong as the tTG autoantibody tests, they still populate reference laboratory menus and are definitely worth mentioning. AGA testing is useful for testing pediatric populations and for individuals wit......ividual amount of change in DAS and the DAS value (low, moderate, high disease activity) reached to classify patients as good, moderate and non-responders. CONTACT: Ginny Valenze of Roche, Office, +1-973-562-2373,Cell,+1-973-943-9219, ; or Becky Lauer of ManningSelvage & Lee,Office, +1-2......kner Group's (BGI) study presentingthe preliminary value proposition for FGF-1 use in advancedcoronary arte...The Bruckner Group's ongoing development ofFGF-1's value proposition has been critical to FGF-1's commercialdevelopment. BGI's findings are allowing CVBT to ...Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
...rms: (a) an exercise price equal to the fairmarket value of the company's common stock on the grant date, (b) aterm of ten years, and (c) a vesting schedule providing that theoption is exercisable as to one-quarter of the total grant on thefirst anniversary of their hire, and one-forty-eighth of the totalg......ics'website later this week. "There is tremendous value in better understandingpharmacogenomics to tailor treatment and improve patient outcomes,"said Kathleen Danenberg, President and CEO of Response Genetics."These results along with previous studies provide strong evidencethat by prospectively defining......kner Group's (BGI) study presentingthe preliminary value proposition for FGF-1 use in advancedcoronary arte...The Bruckner Group's ongoing development ofFGF-1's value proposition has been critical to FGF-1's commercialdevelopment. BGI's findings are allowing CVBT to ...From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
...ndoned as dead-ends,despite their real therapeutic value in terms of prolonging patientsurvival. “Clinical data are providing evidence that patients areliving longer following vaccination, despite the fact that trialsdo not show the vaccines can induce the immune system intoshrinking tumors,”...... property rights, and thetherapeutic or commercial value of its drug candidates, that maycause Lexicon's actual results to be materially different from anyfuture results expressed or implied by such forward-lookingstatements. Information identifying such important factors iscontained under "Factors Affecti......nce interval isestablished when: -- The delta value is 10% or less on the lower bound and includes zer...in or Biaxin(R) is 90% or greater. -- The delta value is 15% or less on the lower bound and includes zero on the upper bound when the higher clinica...Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
...ana 10% share of the Parkinson's disease market by value and theirusage is growing. About Schizophrenia Schizophrenia is a debilitating mentalillness characterized by disturbances such as hallucinations anddelusions as well as a range of negative symptoms, includingcognitive disturbances. Cognitive distur...MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
...Treat patientpopulation. Typically, a probability value (p) less than .05is commonly accepted as establishing statistical significancebetween treatment groups. “With the conclusion of this clinical study, MediQuest isone step closer to submitting the Vascana New Drug Application tothe FDA,” s......tients had detectable CsA levels below0.33ng/ml, a value which is considered as negligible These results are presented at the occasion of a Symposiumchaired by Pr BenEzra, lead coordinator of the study. About Novagali Pharma Vekacia(R): Vekacia(R) is a Cyclosporine A ophthalmic product intended forpatie......ess than sevenpercent at Week 24 had a Week 54 A1C value of less than sevenpercent (n=96 and 33, respective...ess than sevenpercent at Week 24 had a Week 54 A1C value of less than sevenpercent. Over the 54 week study, five out of 182 patients (three percent)treated ......h report published by JainPharmaBiotech, the total value of cell-based markets was $27billion in 2005 and is expected to grow to $96 billion in 2015, asmore than 300 companies are engaged in developing cell-basedalternatives to medical devices and drugs to treat and possiblycure numerous acute and chronic ...... less lessp value t... less lessp value than than(compared to placebo) 0.001 0.001 ...Materia Licenses Metathesis Catalyst Platform to Eisai
...gy in2005. "We are pleased that Eisai accepts the value of Materia'stechnology in drug discovery and process chemistry and look forwardto its exciting progress," stated Dr. Michael Giardello, Materia'sChief Executive Officer. "We believe that this agreement furthervalidates metathesis' broad potential for...Apollo's human proteins boost stem cell research
...umansystems, suggesting that they will be of great value in stem cellresearch. "Ultimately this technology could lead to novel treatments forimportant human diseases such as diabetes and heart disease," hesaid. Professor Alan Trounson from Monash University's Immunology andStem Cell Laboratories and a me......OurEzLifeSciences solutions are providing superior value for growing,innovative customers. LORENZ has successfully developedpurpose-built solutions that can be integrated at ease which willonly enhance our offerings to this industry." About Answerthink Answerthink, Inc. (www.answerthink.com) is a leading...... cell-based therapies. MaxCyte hasdemonstrated the value of its versatile technology in partneredtherapeutic programs in oncology, pulmonary, metabolic andinfectious diseases as well as in development collaborations withleading researchers. Current clinical programs withMaxCyte-engineered cells include: a ......ed, thushelping to calm the STN over-activity. The value of this strategyhas been demonstrated in previous human studies where reducing STNactivity by either electrical stimulation or lesioning can helpameliorate the symptoms of advanced Parkinson's disease. The Phase 1 study was not specifically designed...Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial
...ograms forSurvivin and Myc pathway inhibitors, and value generatingpartnerships with Merck, MedImmune, Medarex, and Novartis. Byutilizing AvalonRx(R) our platform technology, based upon theproprietary use of large-scale gene expressions, we are uniquelypositioned to develop therapeutics focused on pathways......g and marketing novel productsof high therapeutic value for human and veterinarymedicine. In 2006, BoehringerIngelheim posted net sales of 10.6 billion euro while spending one fifth of net sales in its largest business segmentPrescription Medicines on research anddevelopment. For more informati......g themorning, which then decline to reach a trough value at aboutmidnight. In the early morning, a steep increase in blood pressureoccurs. It has been suggested that this morning surge in bloodpressure triggers adverse cardiovascular events. Each year in theUnited States alone acute myocardial infarction d......ividual amount of change in DAS and the DAS value (low, moderate, high disease activity) reached to classify patients as good, moderate and non-responders. CONTACT: Ginny Valenze of Roche, Office, +1-973-562-2783,Cell,+1-973-943-9219, ; or Becky Lauer of ManningSelvage & Lee,Office, +1-2...Haemacure Announces Preliminary Findings of its Plasma Discard Analysis
...vised, these findings are preliminary and the full value ofthese proteins and enzymes cannot be realized without FDA approval.Haemacure will continue identification work on its plasma discardand seek partnerships with pharmaceutical and biotechnologycompanies that would fund the development and clinical ac...Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial
...viously intractable cancer targets. Thecompany has value generating partnerships with Merck, MedImmune,Medarex, and Novartis. Avalon Pharmaceuticals was established in1999 and is headquartered in Germantown, Md. Contacts: Avalon Pharmaceuticals Russo Partners, LLC David D. Muth ......ocuments the efficacy and safetyof Actemra and the value of its IL-6 receptor inhibition. We lookforward to further results from this extensive multinational PhaseIII development programme," commented William Burns, CEO DivisionRoche Pharmaceuticals. The TOWARD trial included approximately 40% of patien...... explained Dr. Philip. "Theseresults highlight the value of continued research to develop newdrugs to fight...is hoped that nationally increasedawareness in the value of clinical trials for cancer patients willallow investigators to ask the maximum number of research......oucester said, "Clinical evidence for romidepsin's value in thetreatment of T-cell lymphomas continues to build. Based on the datafrom this trial, as well as interim data from our ownGloucester-sponsored CTCL pivotal phase II study which is nearingcompletion, we remain enthusiastic about the clinical prosp...Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
...ians, rewarding careers to employees, andincreased value to shareholders. Dedicated to advancing science andmedicine to help people live better lives, the company is focusedon the areas of infectious diseases, cancer and inflammatorydiseases. With more than 2,500 employees worldwide, MedImmune isheadquarte...Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
...I clinicaltrials. Medarex is committed to building value by developing adiverse pipeline of antibody products to address the world's unmethealthcare needs. For more information about Medarex, visit its Website at <a target="_blank" href="http://www.medarex.com/">www.medarex.com . Medarex Statement......dy results are promising and suggest the potential value ofCAELYX in the management of metastatic breast cancer," said RobertJ. Spiegel, M.D., chief medical officer and senior vice president,Schering-Plough Research Institute. "Further evaluation isindicated to confirm that CAELYX is effective and safe fo......t entry were in the low normal range with a median value of 3.7mIU/mL. After three months of treatment LH i...ased significantly to 0.3 in the Androgel group, a value belowthe normal range. After six months of treatment the values for thefour treatment groups were si......ecancer care. The company is committed to creating value by buildinga world-class team, accelerating the development of lead productcandidates, expanding its pipeline by being the alliance partner ofchoice, and nurturing a unique company culture. Additionalinformation on Hana Biosciences can be found at &#...Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in Phase 2 Trial
...ose was statistically superior to placebo with a p value of0.05 and both doses combined were superior to placebo with a pvalue of 0.04. MF101 showed a trend for improvement in severity ofhot flashes compared to placebo with the higher dose showinggreater improvement (p=0.1) than the lower dose (p=0.12) and...New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting
...ct No.2228, Monday, June 4, 2007, 8:50 AM) "Added value of SPECT-CT in patients explored by 111In-CapromabPendetide (ProstaScint)", by Belhocine, et al. (Abstract No. 653,Wednesday June 6, 2007, 9:45 AM) About QUADRAMET QUADRAMET is indicated for the relief of pain in patients withconfirmed osteoblastic...Access and Somanta Announce Data to be Presented on Angiolix at ASCO Oncology Conference
... the efficacy and method of actionof Angiolix, the value of our products in the market, our abilityto achieve clinical and commercial success, our ability tosuccessfully develop marketed products and the ability to obtainthe approvals of Somanta's stockholders, to obtain or meet theclosing conditions in th......ces, electronics, andenergy. Arrowhead is building value for shareholders through theprogress of majority owned subsidiaries founded on nanotechnologiesoriginally developed at universities. The company works closelywith universities to source early stage deals and to generaterights to intellectual property...Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
...ians, rewarding careers to employees, andincreased value to shareholders. Dedicated to advancing science andmedicine to help people live better lives, the company is focusedon the areas of infectious diseases, cancer and inflammatorydiseases. With more than 2,500 employees worldwide, MedImmune isheadquarte......gainst I-R injury is thereforeof great therapeutic value in the prevention and treatment ofIHD. Schisandrin B, an active ingredient from Schisandra Berry, awell-known cardio-tonic in traditional Chinese medicine, has beenshown to possess antioxidant properties. This investigation aims toexamine whether ...MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
...ians, rewarding careers to employees, andincreased value to shareholders. Dedicated to advancing science andmedicine to help people live better lives, the company is focusedon the areas of infectious diseases, cancer and inflammatorydiseases. With more than 2,500 employees worldwide, MedImmune isheadquarte......swith demonstrated safety and efficacy, and adding value throughfurther clinical development and selection of the most viable andrisk-reduced methods of commercialization. The company's pipelineincludes promising early and late-stage drug candidates with uniqueformulations and mechanisms of action that add......d the ability to deliver 25 X reference MIC value of 256 ug/mL in TA (6,400 ug/mL). Patients and Methods: A double-blind, placebo-controlled, study of aerosol AMK delivered via the Pulmonary Drug Delivery System (PDDS, Nektar Therapeutics) in ventilated patients with gram......blic biopharmaceutical company thatseeks to create value for patients, partners and investors bydeveloping innovative therapies for cardiovascular and metabolicdiseases. Speedel is a world leader in renin inhibition, apromising new approach with significant potential for treatingcardiovascular diseases. Ou......et ofnumbers; relates to or constitutes the middle value in adistribution. 50% of the values are above and 50% below the median. Monotherapy: treatment with one drug as opposed to combinationtherapy. Here the term refers to treatment with CYT003-QbG10 alonein contrast to a regimen where CYT003-QbG10 is com...New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace
...hpatients around the world, and an estimate of the value of theglobal market for first-line TB treatments. The study, Pathway to Patients: Charting the Dynamics of theGlobal TB Drug Market, reveals the variability and complexitiesfaced at all levels of the TB drug supply chain; the highlyfragmented nature...Repligen Reports Positive Phase 2 Clinical Trial Results of Secretin for MRI Imaging of the Pancreas
...es, our dependence onthird-party manufacturers and value added resellers, our ability tohire and retain skilled personnel, our volatile stock price, andother risks detailed in Repligen's filings with the Securities andExchange Commission. Repligen assumes no obligation to update anyforward-looking informat...Data Show FluMist May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings
...ians, rewarding careers to employees, andincreased value to shareholders. Dedicated to advancing science andmedicine to help people live better lives, the company is focusedon the areas of infectious diseases, cancer and inflammatorydiseases. With more than 2,500 employees worldwide, MedImmune isheadquarte......ians, rewarding careers to employees, andincreased value to shareholders. Dedicated to advancing science andmedicine to help people live better lives, the company is focusedon the areas of pediatric infectious diseases, cancer andinflammatory diseases. With more than 2,500 employees worldwide,MedImmune is ......ge data analysis so strongly validatesthe clinical value of Curosurf(R)." About Curosurf(R) Curosurf(R) Intratracheal Suspension is indicated for thetreatment (rescue) of RDS in premature infants. Curosurf(R) reducesmortality and pneumothoraces associated with RDS. Curosurf(R) Intratracheal Suspension c......ians, rewarding careers to employees, andincreased value to shareholders. Dedicated to advancing science andmedicine to help people live better lives, the company is focusedon the areas of infectious diseases, cancer and inflammatorydiseases. With more than 2,500 employees worldwide, MedImmune isheadquarte......ished both -- we achieved the lowestblood pressure value ever set in a morbidity/mortality outcomestrial and saw tremendous benefit for the valsartan arm in reducingthe risk of cardiovascular events as well as stroke. Because ofthis, valsartan will play an important role in treatinghypertension as it has b......,000 range that is widelyaccepted as offering good value for money." Supported by Medtronic, this analysis of ITB Therapy'scost-effectiveness is the first in the context of the U.S.healthcare system. "Cost-effectiveness is an important consideration in today'shealthcare environment," said Dr. Richard E. ...Researchers Identify New Genetic Risk Factors for Type 2 Diabetes
...stgenetic risk. This “could potentially have value in apersonalized preventive medicine program,” the researcherswrote. However, the researchers emphasized that their predictions ofdisease risk need to be interpreted with caution because thediabetes group in their sample was “enriched...Other ContentsviabilityviabilityviabilityviabilityviabilityviabilityviabilityvirionorganorganorganorganorganorganorganorganorganviralviralviralviralviralviralviralviralviralvirulencevirulencevirulencevirulencevirulencevisceravisceravitaminsvitaminsvitaminsvitaminsvitaminsOther TagsarosearoseUVarestrestrestrestrest
(Date:9/8/2008)...The American College of Clinical Pharmacology (ACC...ector of Pediatric Clinical Pharmacology at Childr...shed Investigator Award. , Dr. van den Anker, a ... "his sustained and prolific contributions to pedi...P. , The Distinguished Investigator Award is giv...
(Date:9/8/2008)...Children born prematurely are four times more like...ders, according to research led by the University ...artment of Psychology and Warwick Medical School e... who had been born below 26 weeks gestation, known...empted to contact the family of every child born i...
(Date:9/8/2008)...MADISON, WI, September 2, 2008 -- A new interactiv...dents and graduate students how herbicides are dev...Montana State University, has the seal of approval...ences Education and is published in the 2008 issu...on the market today were discovered by random sear...
(Date:9/8/2008)...Sunnyvale, CA September 8, 2008 The U.S. Departm...y Institute of Research (WRAIR) and Arbor Vita Cor...and Development Agreement (CRADA) for research and...ury (TBI). The alliance is based on discoveries m...NO Inc., of Toronto, Canada, and will explore the ...
Breaking Biology News(10 mins):Premature children 4 times more likely to have behavioral disorders 2Arbor Vita and WRAIR sign CRADA for traumatic brain injury collaboration 2Redesigned Blue Shield of California Website Makes Finding a Doctor Online Easier and Faster 6931 1Redesigned Blue Shield of California Website Makes Finding a Doctor Online Easier and Faster 6931 2Streamline Health Solutions Inc Reports Third Quarter Results 6927 1Streamline Health Solutions Inc Reports Third Quarter Results 6927 2Streamline Health Solutions Inc Reports Third Quarter Results 6927 3Streamline Health Solutions Inc Reports Third Quarter Results 6927 4Streamline Health Solutions Inc Reports Third Quarter Results 6927 5Streamline Health Solutions Inc Reports Third Quarter Results 6927 6Streamline Health Solutions Inc Reports Third Quarter Results 6927 7Streamline Health Solutions Inc Reports Third Quarter Results 6927 8Streamline Health Solutions Inc Reports Third Quarter Results 6927 9Streamline Health Solutions Inc Reports Third Quarter Results 6927 10Streamline Health Solutions Inc Reports Third Quarter Results 6927 11Streamline Health Solutions Inc Reports Third Quarter Results 6927 12Pharmacopeia To Present at BMO Capital Markets Seventh Annual Focus on Healthcare Conference 1950 1Pharmacopeia To Present at BMO Capital Markets Seventh Annual Focus on Healthcare Conference 1950 2Pharmacopeia To Present at BMO Capital Markets Seventh Annual Focus on Healthcare Conference 1950 3Design of patient tracking tools may have unintended consequences 6925 1Design of patient tracking tools may have unintended consequences 6925 2Design of patient tracking tools may have unintended consequences 6925 3(Date:9/8/2008)...ncs (around $ 885 thousand, 400 thousand) for ea...e destined by the winners to research projects , ...alzan Prize winners were announced today in a publ...t di Roma "La Sapienza", for the Visual Arts since..., for Moral Philosophy , Ian H. Frazer (Australia...
(Date:9/8/2008)...t. 8 /PRNewswire/ -- Laser scalpels, arthroscopic,...defibrillators --,veterinary medicine is quickly e...s. This work has a side benefit; it,s improving me... increasingly advanced care for their pets to,trea...c problems and,cancer, according to the American V...
(Date:9/8/2008)... LegalView recently reported on the risk of bone f...r (PPI) drugs. The drugs are used to treat and red...er stomach/intestinal issues including ulcers, gas...me forms of stomach infections and Zollinger-Ellis... (PRWEB) September 8, 2008 -- LegalView, the numbe...
(Date:9/8/2008)... Physical therapists, occupational therapists and ...percent employment increases through 2016. , ...eople reach significant milestones through the hel...according to the http://www.nraf-rehabnet.org/ [...ch is holding the 2008 National Rehabilitation Awa...
Breaking Medicine News(10 mins):Health News:Balzan Foundation announced 2008 prize winners 2Health News:Balzan Foundation announced 2008 prize winners 3Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug 2Health News:LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug 3Health News:LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug 4Health News:U.S. Demand for Rehabilitation Professionals Grows 2Health News:U.S. Demand for Rehabilitation Professionals Grows 3preservedarosespectrometrybiomaterialsturgeonthwartsUVaandmaternalcannibalismpropellingrestdancerspoochplaytime
Other Tagsovernight 2overnight 3bird 2bird 3bird 4bird 5bird 6bird 7bird 8bird 9bird 10disaster 2dating 2dictate 2ultimately 2ultimately 3ultimately 4ultimately 5ultimately 6ultimately 7ultimately 8ultimately 9ultimately 10| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |